Tag: Adamas Pharmaceuticals Inc.

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Adamas Pharmaceuticals Inc.

Adamas Pharmaceuticals (ADMS) Sets New 1-Year Low at $6.83

Added to Collection on: 2019-04-03 07:15:00

Tags for this article:

Money
Finance
Economy
Stock
Short
Financial regulation
Adamas Pharmaceuticals Inc.

Click the tags to see associated articles and topics

View Article Details
Sns Financial Group Increases Holding in Cme Group (CME); Adamas Pharmaceuticals (ADMS ...

Added to Collection on: 2019-04-04 01:24:58

Tags for this article:

Finance
NASDAQ
Financial markets
CME Group
Futures exchanges
Chicago Board of Trade
Central European Media Enterprises
Market data
Intercontinental Exchange
NEX Group
Adamas Pharmaceuticals Inc.
Rhenman & Partners Asset Management Ab
S&P 500 INDEX - CBOE
Adamas Pharma

Click the tags to see associated articles and topics

View Article Details
Adamas Pharmaceuticals (ADMS) Hits New 1-Year Low at $6.83

Added to Collection on: 2019-04-04 22:28:27

Tags for this article:

Economy
Short
Financial regulation
Adamas Pharmaceuticals Inc.

Click the tags to see associated articles and topics

View Article Details
78189 Shares in Adamas Pharmaceuticals Inc (ADMS) Acquired by Two Sigma Investments LP

Added to Collection on: 2019-04-08 19:57:20

Tags for this article:

Economy
Short
Financial regulation
Two Sigma Investments LP
Adamas Pharmaceuticals Inc.

Click the tags to see associated articles and topics

View Article Details
Is Adamas Pharmaceuticals Inc (ADMS) A Good Stock To Buy ?

Added to Collection on: 2019-12-15 18:41:15

Tags for this article:

Finance
Money
Investment
Alternative investment management companies
Financial markets
Hedge fund
NASDAQ
Short
Form 13F
Adamas Pharmaceuticals Inc.

Click the tags to see associated articles and topics

View Article Details
Adamas Pharmaceuticals, Inc. (NASDAQ:ADMS) Expected to Post Earnings of -$0.52 Per Share

Added to Collection on: 2021-01-09 10:18:45

Tags for this article:

Finance
Economy
Companies
ANGI Homeservices
IAC
Price?earnings ratio
Securities research
Goldman Sachs
Adamas Pharmaceuticals Inc.

Click the tags to see associated articles and topics

View Article Details
William Blair Brokers Increase Earnings Estimates for Adamas Pharmaceuticals, Inc. (NASDAQ ...

Added to Collection on: 2021-01-18 07:07:30

Tags for this article:

Financial markets
Finance
Money
Stock market
Financial ratios
Dividends
Equity securities
Corporate finance
High-yield stock
Short
Investment
Share
Adamas Pharmaceuticals Inc.

Click the tags to see associated articles and topics

View Article Details
The Daily Biotech Pulse: Vertex, Pfizer Earnings, Tiziana COVID-19 Vaccine Data, Decision Day ...

Added to Collection on: 2021-02-02 12:56:15

Tags for this article:

Companies
Life Sciences
Economy of the United States
Economy of New York City
BioCryst Pharmaceuticals
N-Shares
Pfizer
Vertex Pharmaceuticals
NASDAQ
ARGENX SE
Adamas Pharmaceuticals Inc.
Hologic Inc.
BioCryst Pharmaceuticals Inc.
Abbott Laboratories
Cellular Biomedicine Group Inc.
Fulgent Genetics Inc.
DarioHealth Corp.
Frequency Therapeutics Inc
Harvard Bioscience Inc.
G1 Therapeutics Inc
Laboratory Corp. of America Holdings

Click the tags to see associated articles and topics

View Article Details
$20.79 Million in Sales Expected for Adamas Pharmaceuticals, Inc. (NASDAQ:ADMS) This Quarter

Added to Collection on: 2021-02-03 08:37:30

Tags for this article:

Price?earnings ratio
Pharmaceutical industry in China
Life Sciences
Health care
Health sciences
Adamas Pharmaceuticals Inc.
RUSSELL 2000 PRICE RETURN USD

Click the tags to see associated articles and topics

View Article Details
Adamas Pharmaceuticals, Inc. (NASDAQ:ADMS) Expected to Post Earnings of -$0.47 Per Share

Added to Collection on: 2021-03-11 09:33:45

Tags for this article:

Finance
Money
Financial ratios
Economy
Valuation
Fundamental analysis
Price?earnings ratio
Financial analyst
Earnings per share
Short
Adamas Pharmaceuticals Inc.

Click the tags to see associated articles and topics

View Article Details